Published in:
01-01-2017 | GI Image
Giant Gastric Gastrointestinal Stromal Tumor (GIST)
Authors:
Andrés Navarrete, Dulce Momblán, Raúl Almenara, Antonio Lacy
Published in:
Journal of Gastrointestinal Surgery
|
Issue 1/2017
Login to get access
Abstract
Gastrointestinal stromal tumors (GIST) represent 0.1–3 % of gastrointestinal malignancy. Surgery is the mainstay of treatment, but in high-risk tumors, imatinib can help to achieve better oncological outcomes. We present a rare case of a patient with gastric GIST with very aggressive evolution in a short period of time despite the use of neoadjuvant therapy with imatinib.